The Middle East & Africa Poultry Diagnostics Market size was calculated at USD 36.77 Million in 2024. It is further expected to grow at a CAGR of 10.71% and worth USD 61.15 Million by 2029.
Poultry disease outbreaks are the primary cause of a significant increase in the need for poultry diagnostics. Therefore, the rising prevalence of zoonotic diseases, avian diseases, and growing demand for poultry-derived food products are driving the poultry diagnostics market in MEA. Also, the increasing awareness about poultry health and the growing healthcare spending is fuelling the market growth.
Various poultry diseases, including chronic respiratory diseases, chicken anemia, infectious bronchitis, and avian influenza, are significantly increasing in the region; therefore, the farmers are now seeking a preventative diagnostic that boosts the market growth. As a result, the government has made ongoing efforts to increase farmer awareness of diseases caused by bacteria, fungus, viruses, protozoon infections, environmental stress, and nutritional deficiencies.
Other factors such as increasing point of care, usage of eggs in various sectors, and the huge meat industry further drive the market growth. In addition, technological advancements in the poultry sector in emerging countries such as South Africa, UAE, and Saudi Arabia provide lucrative growth opportunities for the market players to develop innovative products, thereby expanding the regional market growth.
On the other hand, growing awareness of animal health, extensive use of ELISA tests for preliminary screening of all avian disorders due to their high sensitivity, specificity, and cost-effective nature, and government efforts support market growth in the region. In addition, the development of high accuracy and cos-effective enzyme-linked immunosorbent assay test and point of care diagnostics positively influences the market growth. Furthermore, the market strategies by the key market players such as collaborations, acquisitions, and partnerships are encouraging the players to gain a competitive advantage over the competitors.
High feeding costs, increasing production cost of diagnostics are restraining the MEA poultry diagnostics market growth. In addition, the lack of awareness and trade disputes are significant barriers to market growth.
The MEA is projected to register a moderate share in the global poultry diagnostics market during the forecast period. The market growth is projected to be fuelled by the improving poultry infrastructure, continuous research and development activities, and supportive government policies. In addition, the prevalence of avian and zoonotic diseases, mergers and acquisitions between the countries, and technological advancement are further fuelling the market growth. South Africa, UAE, and Saudi Arabia are contributing to the regional market expansion.
South Africa is anticipated to witness a significant share in the poultry diagnostics market owing to the increasing initiatives by the government, animal welfare associations, and healthcare spending. Also, the growing consumption of animal-derived products, the introduction of high accuracy and cost-efficient products, and infectious diseases are propelling the market growth.
Similarly, the UAE is likely to witness a considerable share in the poultry diagnostics market during the forecast period. Rising concerns about food safety, growing awareness of infectious diseases, and increasing animal healthcare expenditure boost market growth.
On the other hand, Saudi Arabia is projected to augment a promising share and contribute to the MEA regional market expansion. The market growth is contributed by the increasing animal healthcare awareness, growing demand for poultry-derived food products, and the prevalence of avian outbreaks.
A few of the notable companies operating in the Middle East & Africa poultry diagnostics market profiled in the report are IDEXX Laboratories, QIAGEN, Thermo Fisher Scientific, Zoetis, GD Animal Health, IDVet, AffiniTech, AgroBioTek Internacional, BioNote, BioChek, Boehringer Ingelheim, MEGACORP Diagnostik GmbH, and BioinGentech Biotechnologies.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region